Ovarian tumor targeting of docetaxel-loaded liposomes mediated by luteinizing hormone-releasing hormone analogues: In vivo distribution in nude mice

Arzneimittel-Forschung/Drug Research

Volumn 58, Issue 10, 2008, Pages 529-534

  Qin, Yao ^a   Song, Qing Guo ^a   Zhang, Zhi Rong ^a   Liu, Jie ^a   Fu, Yao ^a   He, Qin ^a   Liu, Ji ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

CAS 114977 28 5; Docetaxel, in vivo distribution, liposomes, nude mice; Liposomes, docetaxel loaded; Luteinizing hormone releasing hormone analogues; Ovarian tumor targeting

Indexed keywords

DOCETAXEL; DOCETAXEL LOADED LIPOSOME; GONADORELIN DERIVATIVE; GONADORELIN DERIVATIVE MEDIATED DOCETAXEL LOADED LIPOSOME; LIPOSOME; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG TARGETING; DRUG TUMOR LEVEL; FEMALE; KIDNEY; LIPOSOMAL DELIVERY; LUNG; MOUSE; NONHUMAN; NUDE MOUSE; OVARY TUMOR; PARTICLE SIZE; SPLEEN; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; UTERUS; ZETA POTENTIAL;

EID: 55949100826     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296553     Document Type: Article

References (11)

1. Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T. Molecular targeting of drug delivery systems to ovarian cancer. J Controlled Release. 2003;91:61-73.
2. Dimitra CB, Eugenia P, Vassiliki M, George NP, Evy MZ, Paul A, et al. Conformational analysis of the nonapeptide leuprorelin using NMR and molecular modeling. J Lett Pept Sci. 2002;8:77-87.
3. Peter VCG., Oswald S, Klaus DS, Günter E. Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: Frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues. Am J Obstet Gynecol. 2002;186:171-179.
4. Guan R, Cui Y. Application of LHRH analogues in treatment of ovarian cancer. J Woman Child Health Res. 2003;14 (6):413-416. (in Chinese)
5. Miyazaki M, Schally AV, Nagy A. Targeted cytotoxic analog of luteinizing hormone2releasing hormone AN-207 inhibits growth of OV21063 human epithelial ovarian cancers in nudemice. Am J Obstet Gynecol. 1999;80:1095-1103.
6. Markman M, Kennedy A, Webster K. Combination chemotherapy with carbop latin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum. J Clin Oncol. 2001;19:1901-1905.
7. Maria LI, Paola B, Silvia A, Barbara S, Franco D, Luigi C. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J. Controlled Release. 2003;91:417-429.
8. da Cruz MT, Simoes S, Pedroso de Lima MC. Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons. J Exp Neurol. 2004;187:65-75.
9. Wu CC, Li L.Y, Zhang D, Song H. Research on synthesis of monocholesterylsuccinate. J. Tianjin Polytechnic University. 2005;6(4): 27-33. (in Chinese)
10. Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Controlled Release. 2007;120:18-26.
11. Tros de Ilarduya C, Arangoa MA, Moreno-Aliaga MJ, Duzgunes N. Enhanced gene delivery in vitro and in vivo by improved transferrin-lipoplexes. J Biochim Biophys Acta. 2002;1561:209-221.